AEON Biopharma, Inc. Quarterly Current Ratio in % from Q3 2021 to Q3 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: AEON Biopharma, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q3 2024.
AEON Biopharma, Inc. Current Ratio for the quarter ending September 30, 2024 was 30.1 %, a 21.1% increase year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	30.1	+5.25	+21.1%	Sep 30, 2024
Q2 2024	55.3	+44.1	+393%	Jun 30, 2024
Q1 2024	49.8	+37.9	+319%	Mar 31, 2024
Q4 2023	57	+44.5	+354%	Dec 31, 2023
Q3 2023	24.9	-20	-44.6%	Sep 30, 2023
Q2 2023	11.2	-82.2	-88%	Jun 30, 2023
Q1 2023	11.9	-171	-93.5%	Mar 31, 2023
Q4 2022	12.6	-298	-96%	Dec 31, 2022
Q3 2022	44.9	-438	-90.7%	Sep 30, 2022
Q2 2022	93.4			Jun 30, 2022
Q1 2022	183			Mar 31, 2022
Q4 2021	311			Dec 31, 2021
Q3 2021	483			Sep 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.